Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside—a Comprehensive Review

被引:0
|
作者
C. Henrique Alves
Eric Farrell
Marijn Vis
Edgar M. Colin
Erik Lubberts
机构
[1] University Medical Center,Department of Rheumatology, Erasmus MC
[2] University Medical Center,Department of Immunology, Erasmus MC
[3] Rotterdam,Department of Oral and Maxillofacial Surgery, Special Dental Care and Orthodontics, Erasmus MC
[4] University Medical Center,Department of Rheumatology
[5] Rotterdam,undefined
[6] ZGT Almelo,undefined
关键词
Arthritis; Inflammation; Osteoclast; Osteoblast; Cytokine; IL-17;
D O I
暂无
中图分类号
学科分类号
摘要
Throughout life, bone is continuously remodelled. Bone is formed by osteoblasts, from mesenchymal origin, while osteoclasts induce bone resorption. This process is tightly regulated. During inflammation, several growth factors and cytokines are increased inducing osteoclast differentiation and activation, and chronic inflammation is a condition that initiates systemic bone loss. Rheumatoid arthritis (RA) is a chronic inflammatory auto-immune disease that is characterised by active synovitis and is associated with early peri-articular bone loss. Peri-articular bone loss precedes focal bone erosions, which may progress to bone destruction and disability. The incidence of generalised osteoporosis is associated with the severity of arthritis in RA and increased osteoporotic vertebral and hip fracture risk. In this review, we will give an overview of different animal models of inflammatory arthritis related to RA with focus on bone erosion and involvement of pro-inflammatory cytokines. In addition, a humanised endochondral ossification model will be discussed, which can be used in a translational approach to answer osteoimmunological questions.
引用
收藏
页码:27 / 47
页数:20
相关论文
共 50 条
  • [21] Animal models of disuse-induced bone loss: study protocol for a systematic review
    Mikkel Bo Brent
    Annemarie Brüel
    Jesper Skovhus Thomsen
    Systematic Reviews, 9
  • [22] RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis
    Stolina, M
    Adamu, S
    Ominsky, M
    Dwyer, D
    Asuncion, F
    Geng, ZP
    Middleton, S
    Brown, H
    Pretorius, J
    Schett, G
    Bolon, B
    Feige, U
    Zack, D
    Kostenuik, PJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (10) : 1756 - 1765
  • [23] Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review
    Fardellone, Patrice
    Salawati, Emad
    Le Monnier, Laure
    Goeb, Vincent
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10) : 1 - 18
  • [24] Inflammatory arthritis and systemic bone loss are attenuated by gastrointestinal helminth parasites
    Sarter, Kerstin
    Kulagin, Manuel
    Schett, Georg
    Harris, Nicola L.
    Zaiss, Mario M.
    AUTOIMMUNITY, 2017, 50 (03) : 151 - 157
  • [25] L-arginine metabolism inhibits arthritis and inflammatory bone loss
    Cao, Shan
    Li, Yixuan
    Song, Rui
    Meng, Xianyi
    Fuchs, Maximilian
    Liang, Chunguang
    Kachler, Katerina
    Meng, Xinyu
    Wen, Jinming
    Schloetzer-Schrehardt, Ursula
    Taudte, Verena
    Gessner, Arne
    Kunz, Meik
    Schleicher, Ulrike
    Zaiss, Mario M.
    Kastbom, Alf
    Chen, Xiaoxiang
    Schett, Georg
    Bozec, Aline
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (01) : 72 - 87
  • [26] A novel murine model for chronic inflammatory alveolar bone loss
    Oz, H. S.
    Ebersole, J. L.
    JOURNAL OF PERIODONTAL RESEARCH, 2010, 45 (01) : 94 - 99
  • [27] Review article: Treatments for bone loss in revision total knee arthroplasty
    Qiu, Yi Yan
    Yan, Chun Hoi
    Chiu, Kwong Yuen
    Ng, Fu Yuen
    JOURNAL OF ORTHOPAEDIC SURGERY, 2012, 20 (01): : 78 - 86
  • [28] Th2 and eosinophil responses ameliorate arthritis and inflammatory bone loss
    Andreev, D.
    Chen, Z.
    Oeser, K.
    Krljanac, B.
    Hueber, A.
    Kleyer, A.
    Weigmann, B.
    Voehringer, D.
    Schett, G.
    Bozec, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 132 - 132
  • [29] LOCAL ACTIVATION OF ENDOGENOUS GLUCOCORTICOIDS ATTENUATE BONE LOSS IN CHRONIC INFLAMMATORY ARTHRITIS
    Hardy, Rowan S.
    Begum, Rumina
    Naylor, Amy
    Saghir, Atif
    Lavery, Gareth
    Filer, Andrew
    Jones, Simon W.
    Buckley, Chris
    Cooper, Mark
    Raza, Karim
    RHEUMATOLOGY, 2017, 56 : 43 - 43
  • [30] Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies
    Brent, Mikkel Bo
    PHARMACOLOGY & THERAPEUTICS, 2023, 244